Advanced search
Publication Cover
Postgraduate Medicine Volume 126, 2014 - Issue 3
Submit an article Journal homepage
252
Views
26
CrossRef citations to date
0
Altmetric
Clinical Features

Physician Adherence to ACR Gout Treatment Guidelines: Perception Versus Practice

Gary. M. Oderda Professor and Director, Pharmacotherapy Outcomes Research Center, University of Utah College of Pharmacy, Salt Lake City, UTCorrespondence[email protected]
, PharmD, MPH,
Aki Shiozawa Global Outcome Research, Takeda Pharmaceuticals International, Inc., Deerfield, IL
, MPH, MBA,
Michael Walsh Research Director, The Modellers, Salt Lake City, UT
, MS,
Kyle Hess Statistical Analyst, The Modellers, Salt Lake City, UT
, MS,
Diana. I. Brixner Professor and Chair, University of Utah Department of Pharmacotherapy; Executive Director, Pharmacotherapy Outcomes Research Center, Salt Lake City, UT
, PhD, RPh,
Michael Feehan University of Utah, College of Pharmacy, Salt Lake City, UT; The Modellers, Salt Lake City, UT
, PhD &
Kasem Akhras (at time of study) Takeda Pharmaceuticals International, Inc., Deerfield, IL
, PharmD show all
Pages 257-267 | Published online: 13 Mar 2015

References

  • . Burns CM, Wortmann RL. Latest evidence on gout management: what the clinician needs to know. Ther Adv Chronic Dis. 2012;3(6):271–286
  • . Khanna D, Fitzgerald JD, Khanna PP, ; American College of Rheumatology. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken). 2012;64(10):1431–1446
  • . Centers for Disease Control and Prevention. Gout. http://www.cdc.gov/arthritis/basics/gout.htm. Accessed May 28, 2013
  • . Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T, . 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and anti-inflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res. Oct. 2012;64(10):1447–61
  • . Luk AJ, Simkin PA. Epidemiology of hyperuricemia and gout. Am J Manag Care. 2005;11( 15 Suppl):S435–S442; quiz S465–468
  • . Bieber JD, Terkeltaub RA. Gout: on the brink of novel therapeutic options for an ancient disease. Arthritis Rheum. 2004;50(8):2400–2414
  • . Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum. 2011;63(10):3136–3141
  • . Terkeltaub RA. Clinical practice. Gout. N Engl J Med. 2003;349(17):1647–1655
  • . Saag KG, Mikuls TR. Recent advances in the epidemiology of gout. Curr Rheumatol Rep. 2005;7(3):235–241
  • . Lawrence RC, Felson DT, Helmick CG, ; National Arthritis Data Workshop. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58(1):26–35
  • . Agudelo C, Wise CM. Crystal-associated arthritis. Clin Geriatr Med. 1998;14(3):495–513
  • . Riedel AA, Nelson M, Joseph-Ridge N, Wallace K, MacDonald P, Becker M. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J Rheumatol. 2004;31(8):1575–1581
  • . Brixner DI, Ho MJ. Clinical, humanistic, and economic outcomes of gout. Am J Manag Care. 2005;11( 15 Suppl):S459–S464
  • . Perez-Ruiz F, Calabozo M, Pijoan J, Herrero-Beites A, Ruibal A. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum. 2002;47(4):356–360
  • . Universal Survey, SurveyHealthcare. SurveyHealthcare Samples and Counts. http://www.surveyhealthcare.com/pdfs/CASRO-US.pdf. Accessed May 13, 2013
  • . Harrold LR, Mazor KM, Peterson D, Naz N, Firneno C, Yood RA. Patients' knowledge and beliefs concerning gout and its treatment: a population based study. BMC Musculoskelet Disord. 2012;13:180
  • . Becker MA, Schumacher HR, Espinoza LR, . The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. Arthritis Res Ther. 2010;12(2):R63
  • . Maue SK, Segal R, Kimberlin CL, Lipowski EE. Predicting physician guideline compliance: an assessment of motivators and perceived barriers. Am J Manag Care. 2004;10(6):383–391
  • . Cabana M. Barriers to guideline adherence. Am J Manag Care. 1998;4( 12 Suppl):S741–744; discussion S745–748

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.